Ann Rita Halvorsen
Oslo University Hospital(NO)University of Oslo(NO)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, MicroRNA in disease regulation, Circular RNAs in diseases, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking(2016)422 cited
- → TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients(2016)118 cited
- → A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer(2016)95 cited
- → The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery(2019)92 cited
- → Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis(2015)91 cited
- → Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab(2018)76 cited
- → Unique microRNA‐profiles in EGFR ‐mutated lung adenocarcinomas(2014)67 cited
- → NSCLC depend upon YAP expression and nuclear localization after acquiring resistance to EGFR inhibitors(2017)63 cited
- → Profiling of microRNAs in tumor interstitial fluid of breast tumors – a novel resource to identify biomarkers for prognostic classification and detection of cancer(2016)57 cited
- → Osteopontin is a prognostic biomarker in non-small cell lung cancer(2013)55 cited